- Joined
- Aug 16, 2007
- Messages
- 2,081
- Reaction score
- 1
Ceftobiprole, the fifth generation cephalosporin which covers MRSA and Pseudomonas. Good candidate for monotherapy...but will also break the hospital antibiotic budget if not controlled.
Basilea Pharmaceutical, a swiss company's stock has tripled in the past 3 or so years... the drug will be comarketed with Johnson and Johnson..which means your favorite Levaquin reps are salivating today...
J&J will probably assasinate me.. because I'll make sure this drug is not added to any formulary..anwhere...while getting Levaquin off the formulary.
Basilea Pharmaceutical, a swiss company's stock has tripled in the past 3 or so years... the drug will be comarketed with Johnson and Johnson..which means your favorite Levaquin reps are salivating today...
J&J will probably assasinate me.. because I'll make sure this drug is not added to any formulary..anwhere...while getting Levaquin off the formulary.